Bringing precision medicine to autoimmune patients through immune pathway profiling.
Cancer patients get genomic testing before treatment. Heart patients get cardiac biomarkers. But autoimmune patients? They're told to "try this medication and see if it works."
PathwayBio was founded to change this. We believe autoimmune patients deserve the same precision medicine approach that's standard in oncology—testing FIRST, then matching treatments to YOUR biology.
Every year, millions of autoimmune patients waste 18-36 months trying medications that won't work for their immune system. During this time:
PathwayBio analyzes your immune pathways—the specific biological routes driving your disease—to match you with treatments designed to block YOUR dysfunction. No more guessing. No more trial-and-error.
PathwayBio serves patients with autoimmune conditions including Crohn's disease, multiple sclerosis, Hashimoto's thyroiditis, and more. We work with both newly diagnosed patients exploring treatment options and treatment-resistant patients who have failed multiple medications.
We're committed to transparency, scientific rigor, and patient empowerment. Every PathwayBio panel is processed at CLIA-certified labs, interpreted using evidence-based immunology, and presented in clear, actionable formats for both patients and physicians.
PathwayBio is a division of Investigate Health Publishing LLC, founded by a patient advocate who spent 12 years and $50,000 navigating the healthcare system for chronic dizziness and autoimmune conditions. We understand the frustration of trial-and-error medicine because we've lived it.
Take control of your autoimmune treatment journey
Get Started →